Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen KT, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Ostenstad B, Brodtkorb M, Kimby EK, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse Ket al.(2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Blood Adv(in press) DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
Köhn-Luque A, Myklebust EM, Tadele DS, Giliberto M, Schmiester L, Noory J, Harivel E, Arsenteva P, Mumenthaler SM, Schjesvold F, Taskén K, Enserink JM, Leder K, Frigessi A, Foo J(2023) Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening data Cell Rep Methods, 3(3), 100417 DOI 10.1016/j.crmeth.2023.100417, PubMed 37056380
Hermansen JU, Yin Y, Urban A, Myklebust CV, Karlsen L, Melvold K, Tveita AA, Taskén K, Munthe LA, Tjønnfjord GE, Skånland SS(2023) A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine Cell Death Discov, 9(1), 125 DOI 10.1038/s41420-023-01426-w, PubMed 37055391